City of Hope

États‑Unis d’Amérique


Commandez votre montre hebdomadaire City of Hope
Quantité totale PI 1 002
Quantité totale incluant filiales 1 274 (+ 276 pour les filiales)
Rang # Quantité totale PI 1 353
Note d'activité PI 3,5/5.0    595
Rang # Activité PI 1 199
Activité incl filiales 3,2/5.0    694
Classe Nice dominante Services scientifiques, technolo...

Brevets

Marques

624 24
54 0
299 0
1
 
Dernier brevet 2025 - Compositions and uses of cd19 ta...
Premier brevet 1981 - Method of testing for particular...
Dernière marque 2025 - CANCER FIGHTERS
Première marque 1984 - CITY OF HOPE

Filiales

2 subsidiaries with IP (261 patents, 15 trademarks)

1 subsidiaries without IP

 S'inscrire grtuitement pour accéder à la liste des filiales

Industrie (Classification de Nice)

Derniers inventions, produits et services

2025 Invention Deterministic mechanoporation for cell engineering. Intracellular delivery of a genetic construc...
Invention Synthetic modified vaccinia ankara (smva) based coronavirus vaccines. Disclosed are synthetic MV...
Invention Activatable masked anti-ctla4 binding proteins. The invention provides activatable masked anti-C...
Invention Methods of modulating cdk7 and flt3 using fused bicyclic compounds. The present disclosure genera...
Invention Poxvirus-based vectors produced by natural or synthetic dna and uses thereof. Disclosed are meth...
Invention Pcna inhibitors for the treatment of myc family associated cancers. Described herein, inter alia,...
Invention Stable and immunogenic cmv vaccine. Reconstituted synthetic Modified Vaccina Ankara (rsMVA) vecto...
P/S Online social networking services in the field of cancer patient support Providing a website feat...
Invention Compounds to inhibit ythdf2, t helper cells lacking expression of ythdf2, and methods to treat ca...
Invention Compounds and compositions including phosphorothioated oligodeoxynucleotide, and methods of use t...
2024 P/S Promoting public awareness of the need for cancer prevention and the need for healthy diets; busi...
P/S Analyzing and compiling business data for natural language and data processing technology, data s...
Invention Chimeric antigen receptors and methods for reducing toxicity. Nucleic acid molecules that include...
Invention Immune cells expressing a hypoxia-dependent chimeric antigen receptor targeted to egfr. Describe...
Invention Methods of reprogramming somatic cells and materials related thereto. Disclosed herein are metho...
Invention Baff-r targeted chimeric antigen receptor-modified t-cells and uses thereof. Provided herein are...
Invention P38 mapk inhibitors and uses thereof. Described herein, inter alia, are p38 MAPK inhibitors and ...
Invention Methods comprising oncolytic viruses expressing cd19t and bispecific t cell engagers. inter aliai...
Invention Methods comprising oncolytic viruses expressing cd19t and bispecific t cell engagers. Described ...
Invention Metformin combination therapy for use in cancer treatment. inter aliainter aliainter alia, for tr...
Invention Targeted chimeric antigen receptor modified t cells for treatment of il13ralpha2 positive maligna...
Invention Methods of making and using regulatory t cells for treatment of autoimmune disorders and cancers....
Invention Constructs targeting prostate-specific membrane antigen (psma) and uses thereof. e.g.e.ge.g., T c...
Invention Adeno-associated virus vector variants for high efficiency genome editing and methods thereof. A...
Invention Multivalent kaposi sarcoma-associated herpesvirus-like particles and uses thereof. Vaccine compo...
Invention Membrane-bound il-12 for cellular immunotherapy. This disclosure relates to, inter alia, cells e...
Invention Clock activators and uses thereof. Described herein, inter alia, are clock activators and uses t...
Invention Pcna inhibitors and uses thereof. inter aliainter alia, are PCNA inhibitors and uses thereof.
Invention Bispecific antibodies and uses thereof. Provided herein are, inter alia, antibody compounds comp...
Invention M6a mrna modification in cancer treatment. Disclosed herein are methods of treating cancer by in...
Invention Methods for in vivo expansion of cd8+ t cells and prevention or treatment of gvhd. Disclosed her...
Invention Expansion of human group 2 innate lymphoid cells and methods of use thereof. Provided herein, in...
Invention Adeno-associated virus compositions for restoring pah gene function and methods of use thereof. ...
Invention Combination therapy for treatment of cancer. Described herein, inter alia, are combination thera...
Invention Chimeric poxvirus compositions and uses thereof. Provided herein are, inter alia, viral composit...
Invention Methods for preparing cells for adoptive t cell therapy. An improved method for preparing T cell...
Invention Cysteine peptide-enabled antibodies. Provided herein are functionalized monoclonal antibodies (m...
2023 P/S Downloadable computer software platforms for database management and data analytics Platform as a...
P/S Telemedicine services; Telehealth services; Medical consultations; Medical services
Invention Compositions for restoring mecp2 gene function and methods of use thereof. Provided herein, inte...
Invention Lipid nanoparticles, nucleic acids, and methods of use. Provided herein are, inter alia, nucleic...
Invention Cmv-hiv specific chimeric antigen receptor t cells. This disclosure relates, inter alia, to comp...
Invention Respiratory tract infection therapeutics against covid-19. Provided herein, inter alia, are comp...
Invention Pcna inhibitors and uses thereof. Described herein, inter alia, are PCNA inhibitors and uses the...
2022 Invention Synthetic modified vaccinia ankara (smva) based coronavirus vaccines. Disclosed are recombinant ...
Invention Nk cells expressing il-15 and checkpoint inhibitors for the treatment of cancer. Provided herein...
Invention Compositions and methods for cell-free dna epigenetic gastrointestinal cancer detection and treat...
Invention Chimeric antigen receptor t cells targeting gd and oncolytic viruses for cancer therapy and treat...
Invention Mir-142 compounds and uses thereof. The disclosure provides, inter alia, compounds comprising To...
Invention Adeno-associated virus compositions and methods of use thereof. Provided herein, inter alia, are...
Invention T-cells for anti-hiv car-t therapy and methods of use. Provided herein are, inter alia, a T-cell...
Invention Truncated domain iv egfr and uses thereof. A truncated EGFR (tEGFR) cell surface molecule and it...
2021 Invention Compositions and uses of cd19 targeted chimeric antigen receptor modified immune cells. CD19 scF...
Invention Oncolytic virus compositions and methods for the treatment of cancer. Provided herein, inter ali...
Invention Methods of treating breast cancer. The present disclosure provides methods and compositions usef...
2020 P/S Downloadable webinars in the field of medical conditions and diseases; Downloadable webinars in t...
2011 P/S Newsletters in the field of medical care, healthcare, disease and chronic illness information, ca...
P/S Providing temporary housing accommodations to patients and families
P/S Healthcare services
P/S Downloadable electronic newsletters in the field of medical care, healthcare, disease and chronic...
P/S Medical and scientific research, namely, conducting clinical trials
P/S Entertainment and recreational services, namely, providing physical fitness and yoga instruction
P/S Charitable fundraising services
2007 P/S Newsletters in the field of medical care, health care, and disease information
2006 P/S Charitable fundraising services Medical research services Hospital services
1996 P/S telephone information services, namely, providing information regarding diseases
1990 P/S providing incentives to people to demonstrate excellence in humanitarian and social endeavors thr...
1984 P/S Hospital and Medical Research Services